| Timothy P Davis, PAC | |
|
9327n 3rd Street, 100, Phoenix, AZ 85020 | |
| (602) 371-3100 | |
| (602) 371-0050 |
| Full Name | Timothy P Davis |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 9327n 3rd Street, Phoenix, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215066246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 1200 (Arizona) | Primary |
| 363A00000X | Physician Assistant | 1200 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Timothy P Davis, PAC 9327 W 3rd Street, 100, Phoenix, AZ 85020 Ph: (602) 371-3100 | Timothy P Davis, PAC 9327n 3rd Street, 100, Phoenix, AZ 85020 Ph: (602) 371-3100 |
News Archive
An article in the July/August issue of the Archives of Facial Plastic Surgery reports that the use of Radiance FN/Radiesse injectable implant material appears effective and well tolerated by patients undergoing facial soft tissue augmentation, and patient satisfaction with treatment is high.
New research has established the first global benchmarks for assessing lung function across the entire life span. The lung growth charts will help healthcare professionals better understand lung disease progression and help raise awareness of lung disease, which is the world's leading cause of death.
A series of new reports from Consumer Reports Best Buy Drugs (BBD) caution that the benefits of statin use by children and some women may not outweigh the risks. Drugs to lower cholesterol - including statins - are the most commonly prescribed drugs in the U.S. and garnered more than $14 billion in sales last year.
PDI, Inc., a leading provider of sales and marketing support to U.S. pharmaceutical companies, selected Veeva System's VBioPharma CRM Primary Care and Special Care Editions, VMobile, and VInsights – all part of the Veeva CRM suite of multi-tenant SaaS applications. This marks PDI's continued commitment to the technology advances in the world of cloud computing where business spending on SaaS/Cloud applications is expected to rise 22% this year to $9.6 billion, according to Gartner.
My research lab studies several classes of systems. We are mostly interested in looking at large protein assemblies to understand their structure, dynamics and how their properties relate to their malfunction in disease.
› Verified 3 days ago